Fundies.
English

Stoke Therapeutics, Inc.

EDGAR
STOK Current report (8-K) · filed 2026-10-29

Annual consolidated revenue for 2025: about USD 184.4M, using the latest reported figures. The previous period, 2024, was about USD 36.56M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

9.33 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

-701.65%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -65429000 USD Source
  • Revenue: 9325000 USD Source

Operating cash flow

-56.6 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -117167000 USD Source
  • Operating Cash Flow: -60582000 USD Source

Free cash flow

-58.6 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -117167000 USD Source
  • Operating Cash Flow: -60582000 USD Source
  • Capital Expenditure: 2329000 USD Source
  • Capital Expenditure: 353000 USD Source
Cash and cash equivalents
110 million USD Source
Exact value

110004000 USD

Long-term debt including current maturities
Not available
Shares outstanding
62.4 million shares Source
Exact value

62402595 shares

Reported share-count change

14.03% · 7.68 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 54723455 shares · 2025-06-30· Source
  • 62402595 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

27.6 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Revenue: 10632000 USD · 2025-07-01 – 2025-09-30 Source
  • Revenue: 184420000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 183018000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 6229000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 9325000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-208 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -38347000 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: -6885000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: 51049000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -50003000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -61618000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-178 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: 76039000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: 106405000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: 45585000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: 76039000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -60582000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -117167000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -60582000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

2.69 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Capital expenditure: 438000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 306000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 670000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 438000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 353000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 2329000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 353000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-181 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: 76039000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: 106405000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: 45585000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: 76039000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -60582000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -117167000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -60582000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 438000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 306000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 670000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 438000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 353000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 2329000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 353000 USD · 2026-01-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-29.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 4 of 11 periods available· newest 2025-12-31
  • Operating income: 8 of 11 periods available· newest 2025-12-31
  • Net income: 8 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 8 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 8 of 11 periods available· newest 2025-12-31
  • Total assets: 4 of 11 periods available· newest 2025-12-31
  • Total liabilities: 4 of 11 periods available· newest 2025-12-31
  • Current assets: 4 of 11 periods available· newest 2025-12-31
  • Current liabilities: 4 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 4 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 4 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +404.5%

    Prior period

    USD 36.56 million

    –

    Current period

    USD 184.42 million

    –

    Exact inputs and evidence

    184420000 − 36555000 = 147865000 USD

    36555000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    184420000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 82.1 million

    Prior period

    −USD 88.98 million

    –

    Current period

    −USD 6.89 million

    –

    Exact inputs and evidence

    -6885000 − -88981000 = 82096000 USD

    -88981000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -6885000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 132.44 million

    Prior period

    −USD 86.85 million

    –

    Current period

    USD 45.59 million

    –

    Exact inputs and evidence

    45585000 − -86851000 = 132436000 USD

    -86851000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    45585000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +230%

    Prior period

    USD 203,000

    –

    Current period

    USD 670,000

    –

    Exact inputs and evidence

    670000 − 203000 = 467000 USD

    203000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    670000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 184.42 million 100% of revenue
  • Operating costs Derived USD 205.01 million 111% of revenue
  • Operating income −USD 20.59 million −11% of revenue
  • Tax, interest and other Derived −USD 13.71 million −7.4% of revenue
  • Net income −USD 6.89 million −3.7% of revenue

Cash

  • Operating cash flow USD 45.59 million 25% of revenue
  • Capital expenditure USD 670,000 0.4% of revenue
  • Free cash flow Derived USD 44.92 million 24% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2022 Operating loss: operating costs were 941% of revenue.
  • 2023 Operating loss: operating costs were 1,407% of revenue.
  • 2024 Operating loss: operating costs were 377% of revenue.
  • 2025 Operating loss: operating costs were 111% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2022 2022-01-01 – 2022-12-3112405000 116761000 Derived -104356000 -3289000 Derived -101067000 -35828000 Derived
Source
2023 2023-01-01 – 2023-12-318780000 123553000 Derived -114773000 -10074000 Derived -104699000 -82683000 Derived
Source
2024 2024-01-01 – 2024-12-3136555000 137927000 Derived -101372000 -12391000 Derived -88981000 -87054000 Derived
Source
2025 2025-01-01 – 2025-12-31184420000 205010000 Derived -20590000 -13705000 Derived -6885000 44915000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 184.4M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.199.2M149.4M99.6M49.8M0.02022202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2022Revenue12405000
2023Revenue8780000
2024Revenue36555000
2025Revenue184420000

Revenue growth

Change in revenue from the same financial period one year earlier.

404.5% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.439%313%188%62%-64%2022202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2022Year over yearNo prior comparable period
2023Year over year-29.2%
2024Year over year316.3%
2025Year over year404.5%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -11.2% 2025
Net margin -3.7% 2025
Free cash flow margin 24.4% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.131%-255%-641%-1,028%-1,414%2022202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2022Operating margin-841.2%
2023Operating margin-1,307.2%
2024Operating margin-277.3%
2025Operating margin-11.2%
2022Net margin-814.7%
2023Net margin-1,192.5%
2024Net margin-243.4%
2025Net margin-3.7%
2022Free cash flow margin-288.8%
2023Free cash flow margin-941.7%
2024Free cash flow margin-238.1%
2025Free cash flow margin24.4%

Operating cash flow

Cash generated by the company’s normal business operations.

USD 45.6M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.56.2M17.8M-20.6M-59.0M-97.4M2022202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2022Operating cash flow-31866000
2023Operating cash flow-81067000
2024Operating cash flow-86851000
2025Operating cash flow45585000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 44.9M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.55.5M17.2M-21.1M-59.3M-97.6M2022202320242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2022Free cash flow-35828000
2023Free cash flow-82683000
2024Free cash flow-87054000
2025Free cash flow44915000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

15.8% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.32.5%24.4%16.3%8.1%0.0%2022202320242025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2022Liabilities / assets27.8%
2023Liabilities / assets30.1%
2024Liabilities / assets15.7%
2025Liabilities / assets15.8%

Current assets to current liabilities

Current assets divided by current liabilities.

5.28× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8.40×6.30×4.20×2.10×0.00×2022202320242025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2022Current assets / current liabilities7.77×
2023Current assets / current liabilities6.99×
2024Current assets / current liabilities5.81×
2025Current assets / current liabilities5.28×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2018 2018-01-01 – 2018-12-31
−USD 12.52 million
Exact value

Exact value: -12521000 USD

2018-01-01 – 2018-12-31: -12521000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 10.96 million
Exact value

Exact value: -10964000 USD

2018-01-01 – 2018-12-31: -10964000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 935,000
Exact value

Exact value: 935000 USD

2018-01-01 – 2018-12-31: 935000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 11.9 million
Calculation and evidence

-10964000 − 935000 USD

Exact free cash flow: -11899000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 32.33 million
Exact value

Exact value: -32325000 USD

2019-01-01 – 2019-12-31: -32325000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 31.06 million
Exact value

Exact value: -31055000 USD

2019-01-01 – 2019-12-31: -31055000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.64 million
Exact value

Exact value: 1635000 USD

2019-01-01 – 2019-12-31: 1635000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 32.69 million
Calculation and evidence

-31055000 − 1635000 USD

Exact free cash flow: -32690000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 52.24 million
Exact value

Exact value: -52243000 USD

2020-01-01 – 2020-12-31: -52243000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 42.22 million
Exact value

Exact value: -42221000 USD

2020-01-01 – 2020-12-31: -42221000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.05 million
Exact value

Exact value: 1050000 USD

2020-01-01 – 2020-12-31: 1050000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 43.27 million
Calculation and evidence

-42221000 − 1050000 USD

Exact free cash flow: -43271000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 85.81 million
Exact value

Exact value: -85805000 USD

2021-01-01 – 2021-12-31: -85805000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 66.91 million
Exact value

Exact value: -66907000 USD

2021-01-01 – 2021-12-31: -66907000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.2 million
Exact value

Exact value: 1200000 USD

2021-01-01 – 2021-12-31: 1200000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 68.11 million
Calculation and evidence

-66907000 − 1200000 USD

Exact free cash flow: -68107000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 101.07 million
Exact value

Exact value: -101067000 USD

2022-01-01 – 2022-12-31: -101067000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 31.87 million
Exact value

Exact value: -31866000 USD

2022-01-01 – 2022-12-31: -31866000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.96 million
Exact value

Exact value: 3962000 USD

2022-01-01 – 2022-12-31: 3962000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 35.83 million
Calculation and evidence

-31866000 − 3962000 USD

Exact free cash flow: -35828000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 104.7 million
Exact value

Exact value: -104699000 USD

2023-01-01 – 2023-12-31: -104699000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 81.07 million
Exact value

Exact value: -81067000 USD

2023-01-01 – 2023-12-31: -81067000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.62 million
Exact value

Exact value: 1616000 USD

2023-01-01 – 2023-12-31: 1616000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 82.68 million
Calculation and evidence

-81067000 − 1616000 USD

Exact free cash flow: -82683000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 88.98 million
Exact value

Exact value: -88981000 USD

2024-01-01 – 2024-12-31: -88981000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 86.85 million
Exact value

Exact value: -86851000 USD

2024-01-01 – 2024-12-31: -86851000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 203,000
Exact value

Exact value: 203000 USD

2024-01-01 – 2024-12-31: 203000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 87.05 million
Calculation and evidence

-86851000 − 203000 USD

Exact free cash flow: -87054000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 6.89 million
Exact value

Exact value: -6885000 USD

2025-01-01 – 2025-12-31: -6885000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 45.59 million
Exact value

Exact value: 45585000 USD

2025-01-01 – 2025-12-31: 45585000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 670,000
Exact value

Exact value: 670000 USD

2025-01-01 – 2025-12-31: 670000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 44.92 million
Calculation and evidence

45585000 − 670000 USD

Exact free cash flow: 44915000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

41 filings · 1,901 latest values · 1,901 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001623526, 1623526, STOK, edgar:1623526

Also known as ASOthera Pharmaceuticals, Inc., Stoke Therapeutics, Inc.